Skip to content
Disability, Medical Health Aged Care

Sutherland Shire Now Home To Advanced Neurological Therapy Equipment

Earned Media < 1 mins read

A local Sutherland Shire based company called Aevum Physiotherapy has just invested around a million dollars in advanced neurological therapy equipment to provide sufferers of neurological conditions in Sydney with unparalleled access to the world's best equipment.

Local hospitals do not have anything like this technology supporting neurological therapy. 


This includes one of the world's most advanced treadmills called a Motek C-Mill (
which is one of only two in Australia) that uses augmented and virtual reality to simulate challenging everyday scenarios, allowing patients to practice walking and navigating in complex, dynamic environments.

There is a huge need for people to be aware of what options they have to rehabilitate and restore their function and independence in Sydney Metro.

They have many patients that the equipment has helped who are keen to be interviewed to help let more people know about the huge benefits of neurological therapy technology.

Would you be interested in coming down to the practice in Kirrawee to see it first hand and meet a patient and discuss how it works with a physiotherapist?

More info available here - https://www.aevumhealth.com.au/neurohub


Contact details:

Media Contact:

Nick Brogden

Earned Media

[email protected]

0146168991

 

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.